By on February 09, 2017

Originally published in High Times (Feb. 2017)

“This changes everything!” That was the immediate reaction of Bay Area journalist Fred Gardner as he stood in the office of Steep Hill Laboratory in Oakland and eyed a chromatogram showing the unusual cannabinoid content of a hitherto unknown marijuana strain. The year was 2009, and the strain of interest, an oddity called Soma A-Plus, didn’t top the charts with THC (tetrahydrocannabinol), aka The High Causer, unlike several thousand other bud samples that Steep Hill had previously tested for California medical marijuana dispensaries and growers.

Soma A-Plus was the first of a handful of soon-to-be discovered cannabis strains imbued with a significant amount of cannabidiol (CBD), a compound with intriguing medical attributes.

Read the full article here: